Experts of the Pharmacoeconomics Department are involved in an EU4Health-project “Capacity building to support the uptake of biosimilars in a multistakeholder approach” (AUGMENT Biosimilars), acting as the consortium lead for the project. The AUGMENT Consortium, together with the...
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Webinar: Biosimilar Policies in Practice – Key Findings from the AUGMENT Study Visits
GÖG-Colloquium | Collaborating with WHO to improve affordable access of quality-assured medicines
Ensuring equitable access to safe, effective, quality-assured, and affordable essential medicines remains a key challenge for health systems worldwide. The World Health Organization (WHO) supports its Member States through the development of global norms and standards, the...
New publication: PPRI Pharma Brief Austria 2026 now available in German
The PPRI Pharma Brief Austria 2026 is now available in German, providing a concise and accessible overview of the Austrian pharmaceutical system for German-speaking audiences. Based on the English country report, the publication covers the key features of Austria's pharmaceutical...